$0.1805
0.00170.95%
At close: Nov 13, 4:00 PM EST
$0.1788
-0.0017-0.94%
After Hours: Nov 13, 7:05 PM EST
Vistagen Therapeutics Inc
VTGNNASDAQ
Vistagen Therapeutics (VTGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 13, 2026 | $-0.24 | $-0.37 | 35.1 % |
| Q1 | Aug 14, 2026 | $-0.30 | $-0.35 | 14.3 % |
| Q4 | Jun 15, 2026 | $-0.37 | $-0.30 | -23.3 % |
| Q3 | Feb 12, 2026 | $-0.45 | $-0.39 | -15.4 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 13, 2026 | $138.00K | $250.00K | -44.8 % |
| Q1 | Aug 14, 2026 | $1.48M | $166.67K | 785.6 % |
| Q4 | Jun 15, 2026 | $465.00K | $320.00K | 45.3 % |
| Q3 | Feb 12, 2026 | $303.00K | $256.52K | 18.1 % |
| Metric | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.35 | $-0.30 | $-0.39 |
| Actual | $-0.24 | $-0.30 | $-0.37 | $-0.45 |
| Surprise | +35.1% | +14.3% | -23.3% | -15.4% |
| Revenue | ||||
| Estimate | $250000 | $166670 | $320000 | $256520 |
| Actual | $138000 | $1.5M | $465000 | $303000 |
| Surprise | -44.8% | +785.6% | +45.3% | +18.1% |
| Metric | Q3 '27E | Q4 '27E | Q1 '28E | Q2 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.35 | $0.03 | $0.21 |
| Revenue | ||||
| Consensus | $250000 | — | — | — |
